Mather A. Carscallen

Mascoma Corp. develops technology for abundant biomass conversion. The firm operates through its bioprocessing technology platform, develops bioengineered yeasts and other microorganisms. It also designs and manufactures equipment that processes cellulosic biomass for further biological or chemical conversion. The company was founded by Lee R. Lynd, Charles E. Wyman and Robert J. Johnsen in 2005 and is headquartered in Waltham, MA.

Fluor Enterprises, Inc. provides engineering, procurement, construction, maintenance and project management services. It works with governments and clients in diverse industries around the world to design, construct, and maintain complex and challenging capital projects. The company is headquartered in Irving, TX.

Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism.

Iogen Corp. develops and implements processes for making cellulosic biofuels. It is a technology and project development firm specializing in cellulosic biofuels and renewable transportation fuels that are made from the non-food portion of plant materials and that can be used in today’s cars. The firm uses modern enzymatic hydrolysis technology to produce commercial quantities of cellulosic ethanol for field demonstrations and also developed new ways to use biogas to make transportation fuels. Iogen was founded by Patrick Foody Sr. in 1974 and is headquartered in Ottawa, Canada .

Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada.

Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada.

The Canadian Generic Pharmaceutical Association provides generic prescription medicines and active pharmaceutical ingredients. The company was founded in 1984 and is headquartered in Toronto, Canada.

Norgine BV engages in development and manufacture of pharmaceutical products. It is specialized in gastroenterology, hepatology, cancer, and supportive care. The firms brands include Depoint, Elantan, Emselex, Estraderm, Givalex, Isoket, Nortussine, Provames, Sintrom, Speciafoldine, Surgestone, and Tredemine. The company was founded by Victor Stein in 1906 and is headquartered in Amsterdam, the Netherlands.

Part of Deloitte LLP (New York), Deloitte Development LLC provides legal and auditing services. The company is based in New York, NY.

Part of Teva Pharmaceutical Industries Ltd., Teva Canada Ltd. is a Canadian company that deeply cares about the wellbeing of patients, caregivers, and communities. The company serves 200 million people every day, offering a unique perspective on health through their leadership in generic and brand-name medicines, as well as innovative solutions for healthcare partners. The company is based in Toronto, Canada. Sandy Lee's journey with Teva started in 1988 when she accepted a position as a secretary in Teva's regulatory affairs department.

Taro Pharmaceuticals, Inc. manufacturer and supplier of topical dermatological products. It’s products includes Taro Rx and Taro OTC. It develops creams ointments and gels and also have a growing line of solid dosage from products. It’s customer includes wholesalers, drugstore chains, mass volume retailers, healthcare institutions, independent drug stores and discount retailers. The company was founded in 1950 and is headquartered in Brampton, Canada.

Part of PharmaZell GmbH, Zellbios GmbH is a German company that specializes in manufacturing cdmo solutions, supplying specialty api products, and producing anticancer drugs. Zellbios is based in Raubling, DE, and Sylke Hassel has been the CEO of the company since 2022. The company offers a wide range of reliable services for small molecule apis and biopharmaceuticals to innovators. Zellbios also supports innovative agrochemical companies with their apis for fungicides, insecticides, and herbicides in a safe and sustainable way. The company provides cdmo services for highly potent apis and cytotoxics and is an expert in pre-formulated nitroglycerin production.

Clarify Health Solutions, Inc. develops real-time care guidance technology solutions. Its platform connects patients, clinicians, and managers with an information they need; stratifies patients based on clinical and non-clinical characteristics; collects real-time data on patient?s progress; detects potential complications before they happen; and prompts patients and care providers to act. The company was founded by Jean Drouin and Todd J. Gottula in 2015 and is headquartered in San Francisco, CA.

Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022.

Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on September 30, 2008 and is headquartered in Toronto, Canada.

Axplora is a German company that focuses on delivering sustainable and technologically advanced API products and services. The private company is based in Raubling, Germany. The company's goal is to benefit people, patients, and the planet. The CEO of the company is Sylke Hassel.